https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-20 09:02:152023-09-20 09:02:15Poolbeg Pharma plc – Immunomodulator I Patent Portfolio Strengthened
https://www.optimumcomms.com/wp-content/uploads/2023/06/Novo_Holdings23_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-19 08:37:502023-09-19 08:37:50Novo Holdings invests in innovative water treatment pioneer, HPNow, as part of €14m round
https://www.optimumcomms.com/wp-content/uploads/2023/02/FM_Logo_300px.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-18 07:30:302023-09-18 07:30:30Futura Medical plc – Interim Results 2023
https://www.optimumcomms.com/wp-content/uploads/2023/08/4SC_Logo_300x180px-80x80Web_Logos-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-15 08:09:312023-09-15 08:09:314SC: RESMAIN study data to be presented at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting
https://www.optimumcomms.com/wp-content/uploads/2023/06/Novo_Holdings23_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-14 08:45:102023-09-14 08:45:10Glentra Capital, a new energy transition investment firm backed by large Danish investors, announces first close of EUR 443 million
https://www.optimumcomms.com/wp-content/uploads/2023/09/hervolution-final-pastel-white.png
1804
3664
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-13 08:44:132023-09-13 08:44:13HERVOLUTION Therapeutics appoints Moderna Co-Founder and MIT Professor Robert S. Langer as Chair of its Scientific Advisory Board
https://www.optimumcomms.com/wp-content/uploads/2023/06/Synaffix_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-13 08:40:262023-09-13 08:40:26ABL Bio Taps into Synaffix ADC Technology
https://www.optimumcomms.com/wp-content/uploads/2023/06/Poolbeg_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-13 07:10:312023-09-13 07:10:31Poolbeg Pharma plc – Interim results for the six months to 30 June 2023
https://www.optimumcomms.com/wp-content/uploads/2023/07/IO-Biotech.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-12 13:08:582023-09-12 13:08:58IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ariceum_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-07 08:12:262023-09-07 08:12:26Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer
https://www.optimumcomms.com/wp-content/uploads/2023/07/IO-Biotech.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-06 13:38:422023-09-06 13:38:42IO Biotech Announces Participation in Upcoming Investor Conferences
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-06 07:04:052023-09-06 07:04:20Vicore Pharma Announces Presentations at the European Respiratory Society (ERS) International Congress 2023
https://www.optimumcomms.com/wp-content/uploads/2023/02/Alchemab_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-05 08:37:222023-09-05 08:37:22Alchemab Therapeutics CEO to Present at Wells Fargo 2023 Healthcare Conference
https://www.optimumcomms.com/wp-content/uploads/2023/08/Bioinnovation_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-09-05 08:09:192023-09-05 08:09:19Six companies enter BioInnovation Institute’s Venture House program receiving additional financial support
https://www.optimumcomms.com/wp-content/uploads/2023/08/Astraveus.png
180
300
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-08-31 14:29:562023-08-31 14:29:58Astraveus Appoints Microfluidic expert Etienne Fradet as Chief Technical Officer
https://www.optimumcomms.com/wp-content/uploads/2023/07/Template_Logo_300x180px-80x80Web_Logos-2.png
180
300
Marketing Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Marketing Team2023-08-31 10:23:312023-08-31 10:53:33Lytix Biopharma presents first half and second quarter 2023 results
https://www.optimumcomms.com/wp-content/uploads/2023/08/Bioinnovation_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-08-31 08:36:252023-08-31 08:39:37The BioInnovation Institute welcomes eight new companies to its Venture Lab program
https://www.optimumcomms.com/wp-content/uploads/2023/06/Serca_Pharmaceuticals_Logo_300x180px-80x80-5.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-08-29 09:33:242023-08-29 09:33:24Serca Pharmaceuticals presents first-in-class strategy for game-changing, post heart-attack cardioprotection at European Society of Cardiology Congress 2023
https://www.optimumcomms.com/wp-content/uploads/2023/07/Template_Logo_300x180px-80x80Web_Logos-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-08-29 08:46:212023-08-29 08:46:21Lytix Biopharma announces completion of patient recruitment in the ATLAS-IT-05 trial
https://www.optimumcomms.com/wp-content/uploads/2023/06/Vicore_Pharma_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-08-24 09:15:272023-08-24 09:15:27Vicore Pharma: Interim Report April-June 2023For more information about Optimum Strategic Communications, please get in touch.
